M&A Deal Summary |
|
|---|---|
| Date | 2019-12-01 |
| Target | Biofarma |
| Sector | Medical Products |
| Buyer(s) | Stada |
| Sellers(s) | Horizon Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1895 |
| Sector | Life Science |
| Employees | 10,435 |
| Revenue | 2.3B EUR (2018) |
Stada is a developer and marketer of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. Stada was founded in 1895 and is based in Bad Vilbel, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 11 |
| Sector (Medical Products) | 4 of 4 |
| Type (Add-on Acquisition) | 7 of 8 |
| Country (Ukraine) | 1 of 1 |
| Year (2019) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-04 |
Walmark AS
Třinec, Czech Republic Walmark is a manufacturer of consumer health products in Central Europe with a unique portfolio of well-established Consumer Health brands across multiple categories. These include vitamins and minerals, children’s health, women’s health, men’s health, joint care, digestive and intestinal, and cough and cold and are set to generate continued strong growth. The company's key brands include e.g. Biopron (gut health), Martians (children’s supplements), Urinal (urinary tract health), Proenzi (joint care), Prostenal (male health), Beliema (vaginal health) and Sinulan (respiratory health). Walmark was established in 1990 and headquartered in Třinec, Czech Republic. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-24 |
GlaxoSmithKline - 15 Consumer Healthcare Brands
United Kingdom GlaxoSmithKline plc's 15 Consumer Healthcare Brands develops and manufactures consumer healthcare products. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 1.6B USD |
| Size | Large |
| Type | Sector Agnostic |
Horizon Capital is a private equity fund manager that targets investments in mid-cap companies with rapid growth and profit potential in Ukraine and Moldova. The firm seeks to invest between $5 million to $20 million per transaction. Horizon Capital uses investment proceeds primarily for expansion and buy-out opportunities in core industries that serve the emerging middle class. These industries include financial services, fast-moving consumer goods (FMCG), retail, manufacturing, and other select sectors. Horizon Capital has offices located in Chisinau, Moldova; Kyiv, Ukraine, and Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 9 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 4 of 5 |
| Country (Ukraine) | 4 of 5 |
| Year (2019) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-10 |
Dobrobut
Kyiv, Ukraine Dobrobut is a private healthcare services provider. Dobrobut owns a wide network of clinics and hospitals, staffed by strong professionals and equipped with modern medical equipment, providing quality care to their patients. Dobrobut was founded in 2001 and is based in Kyiv, Ukraine. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-29 |
Purcari Wineries
Chisinau, Moldova Purcari Wineries is a wine and brandy segment in the Central and Eastern Europe (CEE) region, managing around 1,000 hectares of vineyards and 4 wineries located in Romania and the Republic of Moldova: Purcari, Crama Ceptura, Bostavan, and Bardar. Purcari Wineries was established in 1827 and is based in Chisinau, Moldova. |
Buy | - |
